ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CYTK Cytokinetics Inc

63.61
-1.19 (-1.84%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 738,059
Bid Price 63.09
Ask Price 64.50
News -
Day High 66.12

Low
25.98

52 Week Range

High
110.25

Day Low 64.50
Company Name Stock Ticker Symbol Market Type
Cytokinetics Inc CYTK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.19 -1.84% 63.61 20:00:00
Open Price Low Price High Price Close Price Prev Close
65.00 64.50 66.12 65.34 64.80
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,677 738,059 $ 65.42 $ 48,287,263 - 25.98 - 110.25
Last Trade Time Type Quantity Stock Price Currency
19:56:40 1 $ 63.60 USD

Cytokinetics (CYTK) Options Flow Summary

Overall Flow

Bearish

Net Premium

-1M

Calls / Puts

300.00%

Buys / Sells

60.00%

OTM / ITM

700.00%

Sweeps Ratio

0.00%

Cytokinetics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.73B 103.00M - 7.53M -526.24M -5.11 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cytokinetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CYTK Message Board. Create One! See More Posts on CYTK Message Board See More Message Board Posts

Historical CYTK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week66.8868.7664.1066.281,193,866-3.27-4.89%
1 Month69.8875.7164.1069.671,056,313-6.27-8.97%
3 Months80.4984.0561.3370.352,032,116-16.88-20.97%
6 Months33.03110.2530.3770.412,817,45930.5892.58%
1 Year37.94110.2525.9861.141,893,75425.6767.66%
3 Years26.70110.2517.7248.021,400,24436.91138.24%
5 Years9.19110.257.0138.781,191,21854.42592.17%

Cytokinetics Description

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Your Recent History

Delayed Upgrade Clock